Dietary Prevention of Photodamage in Skin With Grapes

Status Completed

Clinical Trial Summary

To assess the effect of orally administered grape powder on the sunburn reaction in humans.

Clinical Trial Description

To determine whether oral grape powder will result in a reduction in biomarkers associated with basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs). Biomarkers taken from non-sun-exposed skin and UV-exposed skin before and after treatment will be compared.

The ultimate goal of this study will be to generate new knowledge of the photoprotective effect of grape powder on UV exposure. The results may be employed as the basis for a larger clinical trial to evaluate the potential of grapes to prevent non-melanoma skin cancers (NMSCs) and sun damage. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02760160
Study type	Interventional
Source	University of Alabama at Birmingham
Contact
Status	Completed
Phase	N/A
Start date	October 2015
Completion date	September 27, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04103658` - NIR and Skin Cancer Margins	N/A
Completed	`NCT01053819` - Can We Miss Pigmented Lesions in Psoriasis Patients?	Phase 4
Recruiting	`NCT03767348` - Study of RP1 Monotherapy and RP1 in Combination With Nivolumab	Phase 2
Recruiting	`NCT05429866` - Immunological Variables Associated to ICI Toxicity in Cancer Patients	Phase 2
Active, not recruiting	`NCT02636569` - Topical Chemoprevention of Skin Cancer Biomarkers	Phase 2
Completed	`NCT02780934` - Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction	N/A
Completed	`NCT02872909` - Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer	N/A
Withdrawn	`NCT03327064` - A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer	Phase 1/Phase 2
Completed	`NCT00342407` - The Incidence of Breast and Other Cancers Among Female Flight Attendants
Terminated	`NCT04410874` - Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer	Phase 1/Phase 2
Completed	`NCT03693937` - A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
Completed	`NCT04334824` - Hydrochlorothiazide and Risk of Skin Cancer
Recruiting	`NCT05878288` - Deep sequencIng in Cutaneous Squamous CEll caRciNomas	Phase 2
Completed	`NCT01359735` - Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients	Phase 2
Terminated	`NCT04348916` - Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors	Phase 1
Enrolling by invitation	`NCT05257486` - Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
Withdrawn	`NCT03757663` - UV Dosimetry Feedback in NMSC Patients	N/A
Completed	`NCT04116983` - DERM NMSC Validation Study
Active, not recruiting	`NCT06227416` - Skin Tumor Biomarkers by Mass Spectrometry Imaging	N/A
Recruiting	`NCT05932511` - Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer	Early Phase 1